NO20033679L - Nye pyrimidinforbindelser - Google Patents

Nye pyrimidinforbindelser

Info

Publication number: NO20033679L
Authority: NO; Norway
Prior art keywords: pyrimidine compounds; new pyrimidine; new; compounds; pyrimidine
Prior art date: 2001-02-20

Application number

NO20033679A

Other languages

English (en)

Other versions

NO20033679D0 (no

Inventor

Stefan Berg

Sven Hellberg

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-20

Filing date

2003-08-19

Publication date

2003-08-19

2003-08-19 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2003-08-19 Publication of NO20033679L publication Critical patent/NO20033679L/no

2003-08-19 Publication of NO20033679D0 publication Critical patent/NO20033679D0/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Psychiatry (AREA)
Diabetes (AREA)
Psychology (AREA)
Virology (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Hospice & Palliative Care (AREA)
Obesity (AREA)
Molecular Biology (AREA)
Emergency Medicine (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO20033679A 2001-02-20 2003-08-19 Nye pyrimidinforbindelser NO20033679D0 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE0100569A SE0100569D0 (sv)	2001-02-20	2001-02-20	New compounds
PCT/SE2002/000271 WO2002065979A2 (en)	2001-02-20	2002-02-18	(diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes

Publications (2)

Publication Number	Publication Date
NO20033679L true NO20033679L (no)	2003-08-19
NO20033679D0 NO20033679D0 (no)	2003-08-19

Family

ID=20283059

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20033679A NO20033679D0 (no)	2001-02-20	2003-08-19	Nye pyrimidinforbindelser

Country Status (23)

Country	Link
US (1)	US7345050B2 (no)
EP (1)	EP1373266A2 (no)
JP (1)	JP4475869B2 (no)
KR (1)	KR20030084935A (no)
CN (1)	CN1294131C (no)
BG (1)	BG108070A (no)
BR (1)	BR0206935A (no)
CA (1)	CA2434648A1 (no)
CZ (1)	CZ20032235A3 (no)
EE (1)	EE200300400A (no)
HK (1)	HK1070071A1 (no)
HU (1)	HUP0303254A2 (no)
IL (1)	IL156781A0 (no)
IS (1)	IS6868A (no)
MX (1)	MXPA03007320A (no)
NO (1)	NO20033679D0 (no)
NZ (1)	NZ526783A (no)
PL (1)	PL363393A1 (no)
RU (1)	RU2003121307A (no)
SE (1)	SE0100569D0 (no)
SK (1)	SK10252003A3 (no)
WO (1)	WO2002065979A2 (no)
ZA (1)	ZA200306171B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0205693D0 (en)	2002-03-09	2002-04-24	Astrazeneca Ab	Chemical compounds
GB0205690D0 (en)	2002-03-09	2002-04-24	Astrazeneca Ab	Chemical compounds
AU2003208479A1 (en)	2002-03-09	2003-09-22	Astrazeneca Ab	4- imidazolyl substuited pyrimidine derivatives with cdk inhibitiory activity
GB0226583D0 (en) *	2002-11-14	2002-12-18	Cyclacel Ltd	Compounds
GB0311276D0 (en)	2003-05-16	2003-06-18	Astrazeneca Ab	Chemical compounds
GB0311274D0 (en)	2003-05-16	2003-06-18	Astrazeneca Ab	Chemical compounds
TW200528101A (en)	2004-02-03	2005-09-01	Astrazeneca Ab	Chemical compounds
US20080207594A1 (en)	2005-05-04	2008-08-28	Davelogen Aktiengesellschaft	Use of Gsk-3 Inhibitors for Preventing and Treating Pancreatic Autoimmune Disorders
UY29827A1 (es) *	2005-10-03	2007-05-31	Astrazeneca Ab	2-amina-pirimidina-4-(2-metil-1-(tetrahidro-2h-piran-4-il)-1-imidazol-5-y1) sustituidas y sus derivados, composiciones farmacéuticas que las contienen, procesos para su preparación y aplicaciones
US20080214560A1 (en) *	2005-10-03	2008-09-04	Astrazeneca Ab	Use of Pyrimidine Derivatives in the Manufacture of a Medicament for Prevention and/or Treatment of Alzheimer's Disease
ATE446294T1 (de) *	2005-11-15	2009-11-15	Array Biopharma Inc	N4-phenyl-chinazolin-4-aminderivate und verwandte verbindungen als inhibitoren der erbb-typ-i- rezeptortyrosinkinase zur behandlung hyperproliferativer krankheiten
TW200811169A (en) *	2006-05-26	2008-03-01	Astrazeneca Ab	Chemical compounds
CA2677096A1 (en) *	2007-01-31	2008-08-07	Vertex Pharmaceuticals Incorporated	Kinase inhibitors
AR069501A1 (es)	2007-11-30	2010-01-27	Genentech Inc	Anticuerpos anti- vegf (factor de crecimiento endotelial vascular)
EP2268612B1 (en) *	2008-03-24	2014-08-20	Novartis AG	Arylsulfonamide-based matrix metalloprotease inhibitors
WO2010009155A2 (en)	2008-07-14	2010-01-21	Gilead Colorado, Inc.	Fused heterocyclyc inhibitor compounds
WO2010009166A1 (en)	2008-07-14	2010-01-21	Gilead Colorado, Inc.	Oxindolyl inhibitor compounds
US8134000B2 (en)	2008-07-14	2012-03-13	Gilead Sciences, Inc.	Imidazolyl pyrimidine inhibitor compounds
JP2011529504A (ja)	2008-07-28	2011-12-08	ギリアードサイエンシーズ，インコーポレイテッド	シクロアルキリデンヒストン脱アセチル化酵素阻害剤化合物およびヘテロシクロアルキリデンヒストン脱アセチル化酵素阻害剤化合物
CN104689316A (zh)	2008-10-22	2015-06-10	弗·哈夫曼-拉罗切有限公司	轴突变性的调节
KR20120013951A (ko)	2009-04-15	2012-02-15	아스트라제네카 아베	알츠하이머병과 같은 글리코겐 신타제 키나제 3 관련 장애의 치료에 유용한 이미다졸 치환된 피리미딘
AU2010259042A1 (en)	2009-06-08	2011-12-15	Gilead Sciences, Inc.	Cycloalkylcarbamate benzamide aniline HDAC inhibitor compounds
CA2763786C (en)	2009-06-08	2014-09-30	Gilead Sciences, Inc.	Alkanoylamino benzamide aniline hdac inihibitor compounds
KR102414221B1 (ko)	2020-08-04	2022-06-27	서울시립대학교 산학협력단	열전 소자 어셈블리, 이의 제조 방법, 및 이를 포함하는 열전 모듈

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
USRE29032E (en) *	1969-06-12	1976-11-09	Riker Laboratories, Inc.	3-Benzoylfluoro-methanesulfonanilides
FR2179493A1 (en) *	1972-04-10	1973-11-23	Roussel Uclaf	Amino benzhydrols - choleretics anticonvulsants sedatives and barbiturate potentiators
DE3042466A1 (de) *	1980-11-11	1982-06-16	A. Nattermann & Cie GmbH, 5000 Köln	N-substituierte (omega) -(2-oxo-4-imidazolin-l-yl)-alkansaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US5521184A (en)	1992-04-03	1996-05-28	Ciba-Geigy Corporation	Pyrimidine derivatives and processes for the preparation thereof
TW225528B (no) *	1992-04-03	1994-06-21	Ciba Geigy Ag
GB9523675D0 (en)	1995-11-20	1996-01-24	Celltech Therapeutics Ltd	Chemical compounds
GB9701453D0 (en) *	1997-01-24	1997-03-12	Leo Pharm Prod Ltd	Aminobenzophenones
GB9919778D0 (en) *	1999-08-21	1999-10-27	Zeneca Ltd	Chemical compounds

2001
- 2001-02-20 SE SE0100569A patent/SE0100569D0/xx unknown
2002
- 2002-02-18 US US10/468,604 patent/US7345050B2/en not_active Expired - Fee Related
- 2002-02-18 PL PL02363393A patent/PL363393A1/xx not_active Application Discontinuation
- 2002-02-18 NZ NZ526783A patent/NZ526783A/en unknown
- 2002-02-18 JP JP2002565540A patent/JP4475869B2/ja not_active Expired - Lifetime
- 2002-02-18 KR KR10-2003-7010874A patent/KR20030084935A/ko not_active Application Discontinuation
- 2002-02-18 IL IL15678102A patent/IL156781A0/xx unknown
- 2002-02-18 BR BR0206935-0A patent/BR0206935A/pt not_active IP Right Cessation
- 2002-02-18 HU HU0303254A patent/HUP0303254A2/hu unknown
- 2002-02-18 CZ CZ20032235A patent/CZ20032235A3/cs unknown
- 2002-02-18 EE EEP200300400A patent/EE200300400A/xx unknown
- 2002-02-18 WO PCT/SE2002/000271 patent/WO2002065979A2/en active IP Right Grant
- 2002-02-18 CN CNB028052471A patent/CN1294131C/zh not_active Expired - Fee Related
- 2002-02-18 MX MXPA03007320A patent/MXPA03007320A/es unknown
- 2002-02-18 SK SK1025-2003A patent/SK10252003A3/sk unknown
- 2002-02-18 RU RU2003121307/04A patent/RU2003121307A/ru not_active Application Discontinuation
- 2002-02-18 CA CA002434648A patent/CA2434648A1/en not_active Abandoned
- 2002-02-18 EP EP02711620A patent/EP1373266A2/en not_active Withdrawn
2003
- 2003-07-08 IS IS6868A patent/IS6868A/is unknown
- 2003-08-07 BG BG108070A patent/BG108070A/bg unknown
- 2003-08-08 ZA ZA200306171A patent/ZA200306171B/xx unknown
- 2003-08-19 NO NO20033679A patent/NO20033679D0/no unknown
2005
- 2005-04-06 HK HK05102865A patent/HK1070071A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
IS6868A (is)	2003-07-08
WO2002065979A3 (en)	2003-02-20
JP2004527486A (ja)	2004-09-09
ZA200306171B (en)	2004-11-08
CN1537112A (zh)	2004-10-13
US7345050B2 (en)	2008-03-18
KR20030084935A (ko)	2003-11-01
RU2003121307A (ru)	2005-02-27
US20040077642A1 (en)	2004-04-22
EP1373266A2 (en)	2004-01-02
SE0100569D0 (sv)	2001-02-20
WO2002065979A2 (en)	2002-08-29
SK10252003A3 (sk)	2004-02-03
BR0206935A (pt)	2004-06-29
JP4475869B2 (ja)	2010-06-09
NO20033679D0 (no)	2003-08-19
IL156781A0 (en)	2004-02-08
CZ20032235A3 (cs)	2004-01-14
PL363393A1 (en)	2004-11-15
CN1294131C (zh)	2007-01-10
EE200300400A (et)	2003-12-15
HK1070071A1 (en)	2005-06-10
MXPA03007320A (es)	2003-12-04
NZ526783A (en)	2005-04-29
CA2434648A1 (en)	2002-08-29
HUP0303254A2 (hu)	2004-01-28
BG108070A (bg)	2004-07-30

Publication	Publication Date	Title
NO20035428D0 (no)	2003-12-05	Nye anti-ineffektiver
NO20033679D0 (no)	2003-08-19	Nye pyrimidinforbindelser
NO20034992D0 (no)	2003-11-10	Nye 4-aninlinokinolin-3-karboksamider
IS6971A (is)	2003-09-29	Ný efnasambönd
NO20025719L (no)	2003-02-03	Nye triazolpyrimidinforbindelser
IS7287A (is)	2004-05-26	Pýrimídín efnasambönd
DK1419152T3 (da)	2011-10-24	HIV-hæmmende pyrimidin-derivater
ATE402148T1 (de)	2008-08-15	Substituierte pyridinylamine
NO20034970D0 (no)	2003-11-07	Nye arylheteroalkylaminderivater
DE50206892D1 (de)	2006-06-29	Substituierte imidazotriazinone
NO20041185L (no)	2004-03-19	Nye sykloheksylsulfoner
ATE435197T1 (de)	2009-07-15	Substituierte 4-aminocyclohexanole
NO20035248D0 (no)	2003-11-26	Nye fenylalkyloksy-fenyl derivater
NO20025902L (no)	2002-12-09	Nye fenylpiperaziner
SE0104366D0 (sv)	2001-12-20	New compounds
SE0102386D0 (sv)	2001-07-03	New compounds
SE0103461D0 (sv)	2001-10-16	New compounds
SE0103437D0 (sv)	2001-10-16	New compounds
SE0102056D0 (sv)	2001-06-08	New Compounds
SE0101958D0 (sv)	2001-06-05	New compounds
SE0100272D0 (sv)	2001-01-30	New compounds
SE0100629D0 (sv)	2001-02-23	New compounds
SE0104342D0 (sv)	2001-12-20	New compounds
SE0101659D0 (sv)	2001-05-11	New compounds
SE0101660D0 (sv)	2001-05-11	New compounds